IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort studyJung-Ta Kao(China Medical University), Yi‐Ying Wu(China Medical University)BMC GastroenterologyApril 24, 201510.1186/s12876-015-0283-5Cited by 65SaveCiteExport RISWatch citationsRelated PapersGSK-3 inhibitors enhance TRAIL-mediated apoptosis in human gastric adenocarcinoma cells|PLoS ONE|2018|13